Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 3/20 | 0.40 |
| ▸ | CTSD | P07339 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.39 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29575915 | 0.94 | SLC7A5 (0.50) | SLC7A5BACE1CTSDSLC1A3SLC1A2 | |
| SCHEMBL29349635 | 0.92 | SLC7A5 (0.52) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL3057410 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL8651654 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL31345674 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL9359613 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL3057413 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| Hydrochloric Acid SCHEMBL17438473 | 0.90 | SLC7A5 (0.53) | SLC7A5BACE1CTSDSMN1; SMN2SLC1A3 | |
| SCHEMBL8527774 | 0.90 | SLC7A5 (0.53) | SLC7A5SLC1A3SLC1A2PDCD1LG2CD274 | |
| SCHEMBL29572280 | 0.90 | SLC7A5 (0.53) | SLC7A5SLC1A3SLC1A2PDCD1LG2CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002436-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2024-01-04 | — | — | US | claimed |
| EP-4247165-A1 | RESPIRATORY TREATMENTS | Hofseth Biocare ASA (NO) | 2023-09-27 | — | — | EP | claimed |
| WO-2022108883-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2022-05-27 | — | — | WO | claimed |
| US-20240002436-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2024-01-04 | — | — | US | disclosed |
| EP-4247165-A1 | RESPIRATORY TREATMENTS | Hofseth Biocare ASA (NO) | 2023-09-27 | — | — | EP | disclosed |
| WO-2022108883-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2022-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002436-A1 | RESPIRATORY TREATMENTS | TSLP, MCOLN3, MCOLN1 | SLC7A5 4783/4885BACE1 3062/4885CTSD 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.